Search results
After key rare disease win, Annexon eyes $144 million raise - San Francisco Business Times
The Business Journals· 1 day agoAnnexon Inc. hopes to sell $125 million of stock following a late-stage clinical trial of a drug...
Cancer vaccine hailed as 'game-changer'
Newsweek· 6 days agoCancer patients in the U.K. are about to get personalized cancer vaccines as part of a new trial. Unlike vaccines for diseases like the flu or COVID-19,...
Antibodies may aid effort to fight influenza B: st | Newswise
Newswise· 7 days agoResearchers at Vanderbilt University Medical Center have isolated human monoclonal antibodies against influenza B, a significant public health threat that disproportionately affects children ...
Alphabet's new CFO was in the middle of the GLP-1 boom. Now she's onto generative AI
NBC Dallas Fort Worth· 3 hours agoAnat Ashkenazi, Alphabet's incoming CFO, has been running the books at Eli Lilly during a period of historic growth. Eli Lilly has emerged as the most valuable drugmaker in the world on the ...
Antibody discovery promises new hope in influenza B battle, paves way for universal vaccine
Medical Xpress· 5 days agoSeasonal flu vaccines cover influenza B and the more common influenza A but do not stimulate the broadest possible range of immune responses against both viruses. In addition, people whose immune ...
Invivyd appoints new Chief Commercial Officer ahead of PEMGARDA launch By Investing.com
Investing.com· 6 days agoInvivyd, Inc. (NASDAQ:IVVD), a company focused on developing treatments for viral infectious...
Analyzing The Emergence Of Covid Variant KP.2 And Its Potential Impact
Forbes· 7 days agoLike influenza, an easily transmissible respiratory virus, SARS-CoV-2 mutates to evade the immune...
Celiac Disease: Five Things to Know
Medscape· 13 hours agoCeliac disease is a chronic, immune-mediated, systemic disorder caused by intolerance to gluten — a protein present in rye, barley, and wheat grains —...
Invivyd aligns with FDA on rapid mAb trial pathway By Investing.com
Investing.com· 6 days agoFood and Drug Administration (FDA) on a new clinical trial pathway for the expedited development of...
EMA Panel Nods to Seven New Cancer Drugs
Medscape· 7 days agoThe drugs include an anti–PD-L1 monoclonal antibody, a biosimilar, and five generics, with indications covering a wide spectrum of cancers.
